DALLAS, Aug. 16 /PRNewswire/ -- Trace Life Sciences and Macrocyclics, Inc. have announced that the two companies will work together on customer projects that require labeled bifunctional chelates for radiopharmaceutical applications. Macrocyclics currently manufactures bifunctional chelating agents that safely link radioisotopes to biological targeting molecules such as antibodies which are valuable tools for imaging and therapy of diseases such as cancer. Trace Life Sciences is a leading producer of radioisotopes for medical imaging and therapy. In particular Trace is now providing GMP grade isotopes such as Cu-64 which promises to have great utility for the fast-growing PET imaging market and Cu-67 which is a key isotope sought after for Radioimmunotherapies (RITs). The close proximity of the two companies provides the ideal environment for rapid production of labeled products which can benefit early-stage clinical development projects.
“We are delighted to have this agreement with our Texas neighbor to help bring the benefits of both companies together - aside from offering radioisotopes to industry and research, this partnership with the talented team at Macrocyclics gives us another dimension to now offer labeled ligands and custom synthesis to the research market in one step. Researchers can now focus on their work and not on the often cumbersome and difficult labeling task,” said Darren Brown, CEO of Trace Life Sciences.
“The collaboration with Trace Life Sciences will expand the scope of our offerings to the radiopharmaceutical community - we can now help customers interested in accelerating advanced research and clinical development programs by providing labeled complexes for imaging and therapeutic applications,” said Garry Kiefer, Director of Operations, Macrocyclics.
For more information, contact: Meagan Skarbek General Manager, Macrocyclics Tel: 972-250-2248 E-mail: Meagan@macrocyclics.comhttp://www.macrocyclics.com Tracey Lane Vice President, Trace Life Sciences Tel: 940-383-6100 E-mail: Tlane@thelinac.comhttp://www.tracelifesciences.com
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
Macrocyclics, Inc.
CONTACT: Meagan Skarbek, General Manager of Macrocyclics, +1-972-250-2248,Meagan@macrocyclics.com; or Tracey Lane, Vice President of Trace LifeSciences, +1-940-383-6100, Tlane@thelinac.com
